Azioni Aegerion Pharmaceuticals, Inc.

Azioni

Tempo differito Nasdaq Altri mercati azionari 22:00:00 29/11/2016			Variaz. 5gg	Var. 1 gen.
1,97 ^USD	+5,35%		+4,23%	-80,50%

Durata

Periodo

Stile

Aegerion Pharmaceuticals, Inc. and QLT Inc. Complete Merger Transaction; QLT to Change Name to Novelion Therapeutics Inc.	29/11/16
Aegerion Pharmaceuticals’ JUXTAPID® (lomitapide) Capsules for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) Receives Pricing Authorization in Japan	17/11/16
Aegerion Pharmaceuticals Announces Third Quarter 2016 Financial Results	03/11/16
Aegerion Pharmaceuticals : Research Reports Coverage on Biotech Stocks -- Merrimack Pharma, Aurinia Pharma, Aegerion Pharma, and TG Therapeutics	24/10/16
Aegerion Pharmaceuticals' : JUXTAPID® (lomitapide) Capsules Approved in Japan for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)	28/09/16

1 giorno

+5,35%

Dirigenti	Titolo	Età	Da
Sheila Frame PSD	President	62	-
Elizabeth Jobes BRD	Director/Board Member	57	-
Ailish Hogan SEC	Corporate Secretary	-	-

Amministratori	Titolo	Età	Da
Sheila Frame PSD	President	62	-
Elizabeth Jobes BRD	Director/Board Member	57	-

Settore